The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer

Journal of the Korean Surgical Society

Volumn 84, Issue 4, 2013, Pages 231-237

  Yu, Hyeon ^a   Son, Gyung Mo ^a   Joh, Yong Geul ^a  

^a Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Carbohydrate antigen 19 9; Colorectal neoplasms; Peritoneal seeding

Indexed keywords

EID: 84876032024     PISSN: 12260053     EISSN: 20930488     Source Type: Journal    
DOI: 10.4174/jkss.2013.84.4.231     Document Type: Article

References (20)

1. Yamashita K, Watanabe M. Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci 2009;100:195-9.
2. Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1865-78. (Pubitemid 32230890)
3. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007; 33:266-70. (Pubitemid 46488663)
4. Zheng CX, Zhan WH, Zhao JZ, Zheng D, Wang DP, He YL, et al. The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World J Gastroenterol 2001;7:431-4. (Pubitemid 32586534)
5. Tan MC. Disorders of the anal canal. In: Sabiston DC, Courtney M. Townsend Jr, editors. Sabiston textbook of surgery: the biological basis of modern surgical practice. 18th ed. Philadelphia: WB Saunders; 2007. p.761.
6. van der Schouw YT, Verbeek AL, Wobbes T, Segers MF, Thomas CM. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. Br J Cancer 1992; 66:148-54.
7. Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, et al. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. Hepatogastroenterology 2003;50:696-9. (Pubitemid 36613383)
8. Park IJ, Choi GS, Jun SH. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer. Anticancer Res 2009;29:4303-8.
9. Lin PC, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, et al. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Colorectal Dis 2012;27:1333-8.
10. Yang SH, Lin JK, Lai CR, Chen CC, Li AF, Liang WY, et al. Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol 2004;87:167-73. (Pubitemid 39167383)
11. Yakabe T, Nakafusa Y, Sumi K, Miyoshi A, Kitajima Y, Sato S, et al. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol 2010;17:2349-56.
12. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-27. (Pubitemid 46631379)
13. Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum 2004;47:227-32. (Pubitemid 38166628)
14. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052-61.
15. Liu F, Yu J, Liang YZ, Hu YF, Wang YN, Li GX. Associated risk factors of peritoneal metastasis in colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2011;14:254-6.
16. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979;5:957-71. (Pubitemid 10132218)
17. Hoff SD, Matsushita Y, Ota DM, Cleary KR, Yamori T, Hakomori S, et al. Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal car cinoma. Cancer Res 1989;49(24 Pt 1):6883-8. (Pubitemid 20016561)
18. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996;179:358-69. (Pubitemid 26276103)
19. Martini F, Guadagni F, Lenti L, D'Alessandro R, Aloe S, Roselli M, et al. CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation. Anticancer Res 2000;20(3A): 1609-14. (Pubitemid 30628173)
20. Nozoe T, Rikimaru T, Mori E, Okuyama T, Takahashi I. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma. J Surg Oncol 2006;94:132-7. (Pubitemid 44267194)